Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Leases Current Taxes Dividends payables Finished Goods Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Others

Envoy Medical (COCH) Non-Current Debt (2024 - 2025)

Envoy Medical's Non-Current Debt history spans 2 years, with the latest figure at $27.9 million for Q2 2025.

On a quarterly basis, Non-Current Debt rose 1017.28% to $27.9 million in Q2 2025 year-over-year; TTM through Jun 2025 was $27.9 million, a 1017.28% increase, with the full-year FY2024 number at $9.3 million, changed N/A from a year prior.
Non-Current Debt hit $27.9 million in Q2 2025 for Envoy Medical, up from $23.1 million in the prior quarter.
Over the last five years, Non-Current Debt for COCH hit a ceiling of $27.9 million in Q2 2025 and a floor of $2.5 million in Q2 2024.